Masimo announced the launch and availability of the Rad-97 Pulse-CO Oximeter® and Next Generation SedLine® Brain Function Monitoring in India. Rad-97 features Measure-through Motion and Low Perfusion SET® pulse oximetry, which studies have shown helps clinicians reduce severe retinopathy of prematurity in neonates, improve CCHD screening in newborns, and, when used for continuous monitoring in post-surgical wards, reduce rapid response activations and costs. Rad-97 also offers the same upgradeable rainbow SET technology as the Radical-7® Pulse CO-Oximeter, in a versatile, standalone monitor configuration. Using Rad-97, clinicians can monitor such rainbow® measurements as total hemoglobin (SpHb®) and PVi®. Studies with SpHb have shown reductions in unnecessary blood transfusion, and when used with PVI, reductions in length of hospital stay and 30- and 90-day mortality. Rainbow® can also measure methemoglobin (SpMet®), acoustic respiration rate (RRa®), carboxyhemoglobin (SpCO®), Oxygen Reserve Index (ORi), and oxygen content (SpOC). Rad-97 also features an integrated camera for clinician tele-presence via Patient SafetyNet and a high-resolution 1080p HD color display with user-friendly multi-touch navigation, similar to Root® and Radical-7, allowing clinicians to easily customize the device to best suit their monitoring needs. SedLine features four simultaneous EEG leads to enable continuous assessment of both sides of the brain, as well as a Density Spectral Array (DSA), an easy-to-interpret, high-resolution display of bi-hemispheric activity. Next Generation SedLine enhances Masimo’s processed EEG parameter, the Patient State Index (PSI), to make it less susceptible to electromyographic (EMG) interference and to improve performance in low-power EEG cases.